C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/07/2002	WO2002034883A3 A one-well assay for high throughput detection of single nucleotide polymorphisms
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002	WO2002024927A3 Regulation of human adam-ts 1 precursor-like protein
11/07/2002	WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002	WO2002012440A3 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
11/07/2002	WO2001092476A3 In vitro tissue test system
11/07/2002	WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002	WO2001086002A9 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/07/2002	WO2001081621A3 Method, diagnostic kit and microarray for determining the rhesus factor
11/07/2002	WO2001075181A3 Method of identifying ginko biloba in a plant extract by gene profiling
11/07/2002	WO2001075161A3 Genetic markers for improved meat characteristics in animals
11/07/2002	WO2001048239A9 Screening method for nucleic acids
11/07/2002	WO2001046406A9 New qtl's on chromosomes x, 2, 6 and 7 of pigs
11/07/2002	WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002	WO2001042784A9 Methods for screening compounds active on neurons
11/07/2002	WO2001029240A9 Regeneration
11/07/2002	WO2001020035A9 Methods and compositions for linear isothermal amplification of polynucleotide sequences
11/07/2002	WO2001020034A9 Methods and compositions for the screening of cell cycle modulators
11/07/2002	WO2001018045A9 Crystal structure of a deacetylase and inhibitors thereof
11/07/2002	WO2001011090A9 Identification of virus-binding polypeptides and nucleotide sequences
11/07/2002	US20020166145 Coffee mannanase
11/07/2002	US20020166138 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/07/2002	US20020166135 Modulation of preferential aspects of nervous system; obtain human, administer modulator, monitor expression of preferential neuropeptides in brain
11/07/2002	US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002	US20020165620 Adding plurality of substrates to plurality of aliquots of test sample, measuring reaction rates between protein and each substrate, determining activity or concentration of protein in test sample using predetermined sensitivity coefficient
11/07/2002	US20020165481 Electrode apparatus and method for the delivery of drugs and genes into tissue
11/07/2002	US20020165388 Contacting DNA or RNA with hydrogen peroxide and radical generating coordination complexes for a time and concentrations to produce aldehydes, reacting with an amine to produce a condensation product and labeling
11/07/2002	US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002	US20020165381 Nucleic acid that codes for an androgen receptor, consists of a prefered nucleotide sequences or nucleotide sequence that corresponds to the sequence from first, or that hydbridizes with above first and second sequences
11/07/2002	US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002	US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165372 Nucleic acid labeling compounds
11/07/2002	US20020165371 Compositions and methods for the therapy and diagnosis of breast cancer
11/07/2002	US20020165370 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector
11/07/2002	US20020165352 Protein complex for use in the diagnosis and treatment of diabetes and nervous system disorders
11/07/2002	US20020165349 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorder and alzheimer's disease
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165345 Prostate cancer gene
11/07/2002	US20020165194 Method for selective inactivation of viral replication
11/07/2002	US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165180 Assaying potential antitumor agents based on their modulation of the expression of specified genes or sets of suspected cancer cell genes, especially for breast cancer
11/07/2002	US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165144 Neuregulin 1 gene (NRG1) and polypeptides
11/07/2002	US20020165143 Identification and isolation of novel DNA
11/07/2002	US20020165139 Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as Bacillus anthrasis
11/07/2002	US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides
11/07/2002	US20020165131 Histidine-rich glycoprotein
11/07/2002	US20020164818 Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
11/07/2002	US20020164803 Nucleotide sequences for use as transformation tools in genetic engineering
11/07/2002	US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002	US20020164793 Generating skin cells; obtain skin cells, keratinocytes and nutrient broths, culture cell, recover cells
11/07/2002	US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002	US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
11/07/2002	US20020164778 Detection apparatus for use in the genetic analysis
11/07/2002	US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164761 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial propagation
11/07/2002	US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002	US20020164757 Plant proteins
11/07/2002	US20020164756 Nucleotide sequences coding polypeptides for use in screening bactericides
11/07/2002	US20020164754 Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans
11/07/2002	US20020164749 Enzymatic polypeptide for use in the diagnosis and treatment of tumors
11/07/2002	US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164733 Peptide for use in human theraeutics and diagnostic
11/07/2002	US20020164722 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002	US20020164701 Polypeptide for use in the diagnosis and treatment of metabolic disorders
11/07/2002	US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002	US20020164683 Human sel-10 polypeptides and polynucleotides that encode them
11/07/2002	US20020164677 High-throughput microbial culturing
11/07/2002	US20020164676 Bacteriological examination system
11/07/2002	US20020164675 Methods of propagating and detecting infectious forms of intracellular pathogenic microorganisms
11/07/2002	US20020164674 Expression vector for use as diagnostic tool in genetic engineering
11/07/2002	US20020164673 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same
11/07/2002	US20020164672 Detecting modulators of preferential enzyme activity; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in enzyme activity
11/07/2002	US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002	US20020164663 Detecting cancer cell which are resistant to tamoxifen; obtain sample, incubate with preferential antibody, measure complex formation, compare to control, evaluate for tamoxifen resistance
11/07/2002	US20020164662 Myeloperoxidase, a risk indicator for cardiovascular disease
11/07/2002	US20020164659 Mixture for use in the detection of preferential particles in sample
11/07/2002	US20020164658 Methods and means of detecting nitric oxide synthase
11/07/2002	US20020164657 Detecting modulators of amyloid complex formation; obtain sample fluid containing aggregated amyloid peptide, incubate with modulator, monitor complex formation, adjustment in complex formation indicates modulator
11/07/2002	US20020164656 Microarrays and uses therefor
11/07/2002	US20020164655 Protein complex for use inthe diagnosis and treatment of nervous system disorders
11/07/2002	US20020164650 Methods of assessing wolframin protein activity
11/07/2002	US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002	US20020164641 Detecting modulators of tyrosine kinase activity; obtain expresion vector containg tyrosine kinase polypeptide, express vector, incubate with modulator, monitor adjustment activity or tyrosine kinase
11/07/2002	US20020164639 Process for determining antibiotics containing a b-lactam ring in biological fluid
11/07/2002	US20020164638 Kit for use in detection of enzyme inhibitors
11/07/2002	US20020164637 Detecting receptor binding ligands; obtain cell extract, incubate with modulator, detect binding, monitor activity from receptor
11/07/2002	US20020164636 High throughput assay for identification of gene expression modifiers

1 ... 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 ... 3003